Open AccessIL-23/IL-17 Axis in Inflammatory Rheumatic Diseases
Author(s) -
Hao Li,
George C. Tsokos
Publication year - 2020
Publication title -
clinical reviews in allergy and immunology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.811
H-Index - 76
eISSN - 1559-0267
pISSN - 1080-0549
DOI - 10.1007/s12016-020-08823-4
Subject(s) - rheumatic disease , medicine , immunology , inflammation , disease , immune system , bioinformatics , biology , pathology , rheumatoid arthritis
In inflammatory rheumatic disorders, the immune system attacks and damages the connective tissues and invariably internal organs. During the past decade, remarkable advances having been made towards our understanding on the cellular and molecular mechanisms involved in rheumatic diseases. The discovery of IL-23/IL-17 axis and the delineation of its important role in the inflammation led to the introduction of many needed new therapeutic tools. We will present an overview of the rationale for targeting therapeutically the IL-23/IL-17 axis in rheumatic diseases and the clinical benefit which has been realized so far. Finally, we will discuss the complex interrelationship between IL-23 and IL-17 and the possible uncoupling in certain disease settings.